Purchase Order HT001417P0718
Award Date 9/30/17
Potential Completion Date 9/30/17
Potential Value $150K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, is for the provision of TYROSEQ V.2 MOLECULAR TESTING services. The $150,000.00 firm fixed price purchase order was issued by the Defense Health Agency and does not have a set-aside designation. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on cancer screening and diagnosis utilizing next generation genomic sequencing under...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $151,200.00. The contract is for the provision of ThyroSeq V.2 molecular testing services, which are used for cancer screening and diagnosis. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on delivering ThyroSeq testing to federal agencies, including the Department...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for a base period of performance from May 1, 2016, to April 30, 2017, with a potential completion date of April 30, 2021. The contract has a ceiling value of $105,000.00 and is for the provision of specialized thyroid cancer diagnostic testing services, including ThyroSeq analysis of genetic mutations, to support cancer screening and diagnosis programs...
- This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., operating as Cblpath, for $72,000.00. The contract is for the delivery of ThyroSeq laboratory tests to determine the malignancy of thyroid nodules in order to support surgical decisions. The contract is not set aside and has a period of performance through August 6, 2026. Cblpath is a for-profit organization specializing in anatomic pathology and molecular diagnostic...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $22,000.00 to provide ThyroSeQ testing services. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and diagnosis. This award is associated with Cblpath's existing Indefinite Delivery/Indefinite Quantity (IDIQ) and Blanket Purchase Agreement...
- This is a firm fixed price purchase order for $77,440.80 awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Cytopath Biopsy Lab Inc. (doing business as Cblpath) to provide laboratory testing services related to the ThyroSeq V.2 molecular diagnostic test. The award supports the agency's cancer screening and diagnosis programs, particularly for veterans and active military members. Cytopath Biopsy Lab Inc. has provided similar ThyroSeq testing services to...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq genetic testing services for the VA's Veterans Integrated Service Network (VISN) 22. The $366,000 contract will support thyroid cancer screening and diagnosis programs at VA healthcare facilities in California, New Mexico, Arizona, and other regional locations. The original solicitation was a...
- The Defense Health Agency awarded a $105,000 firm fixed-price purchase order to Cytopath Biopsy Lab Inc. (doing business as Cblpath) on March 22, 2021, for ThyroSeq molecular diagnostic testing services. The contract, which is scheduled for completion by April 30, 2025, will be performed at Fort Belvoir, Virginia. No set-aside designation was used for this award. Cytopath Biopsy Lab Inc. specializes in anatomic pathology and molecular diagnostic laboratory services, with a primary focus on...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), a civilian agency within the Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc. (operating as Cblpath), a for-profit organization. The $28,000.00 contract is for cytopathology and ThyroSeq genetic testing services to support cancer screening and diagnosis programs for veterans and active military personnel. The contract has an ultimate completion date of May 31, 2025...
- This firm fixed price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of ThyroSeq testing kits. The $320,000.00 contract is to deliver specialized thyroid cancer diagnostic testing services, including ThyroSeq analysis of genetic mutations to evaluate malignancy of thyroid nodules, to support screening programs at VA medical centers and associated healthcare networks...